These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27721961)

  • 1. Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.
    Moghaddasifar I; Lankarani KB; Moosazadeh M; Afshari M; Ghaemi A; Aliramezany M; Afsar Gharebagh R; Malary M
    Int J Organ Transplant Med; 2016; 7(3):149-160. PubMed ID: 27721961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis.
    Hassanipour S; Amini-Salehi E; Joukar F; Khosousi MJ; Pourtaghi F; Ansar MM; Mahdavi-Roshan M; Heidarzad F; Rashidi-Mojdehi G; Abdzadeh E; Vakilpour A; Mansour-Ghanaei F
    Iran J Public Health; 2023 Aug; 52(8):1600-1612. PubMed ID: 37744533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non alcoholic fatty liver disease in southern Iran: a population based study.
    Lankarani KB; Ghaffarpasand F; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Fallahzadeh MK; Maharlouei N; Babaeinejad M; Mehravar S; Geramizadeh B
    Hepat Mon; 2013 May; 13(5):e9248. PubMed ID: 23922564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.
    Tabaeian SP; Rezapour A; Azari S; Martini M; Saran M; Behzadifar M; Shahabi S; Sayyad A; Tahernejad A; Bragazzi NL; Ehsanzadeh SJ; Behzadifar M
    J Clin Exp Hepatol; 2024; 14(1):101209. PubMed ID: 38076354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis.
    Niriella MA; Ediriweera DS; Withanage MY; Darshika S; De Silva ST; Janaka de Silva H
    Lancet Reg Health Southeast Asia; 2023 Aug; 15():100220. PubMed ID: 37614359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis.
    Chegeni M; Nili S; Darabi M; Gheysvandi E; Zahedi R; Sharifian E; Shoraka HR; Rostamkhani M; Gheshlaghi LA
    J Educ Health Promot; 2023; 12():356. PubMed ID: 38144003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    Li J; Zou B; Yeo YH; Feng Y; Xie X; Lee DH; Fujii H; Wu Y; Kam LY; Ji F; Li X; Chien N; Wei M; Ogawa E; Zhao C; Wu X; Stave CD; Henry L; Barnett S; Takahashi H; Furusyo N; Eguchi Y; Hsu YC; Lee TY; Ren W; Qin C; Jun DW; Toyoda H; Wong VW; Cheung R; Zhu Q; Nguyen MH
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):389-398. PubMed ID: 30902670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study.
    Zarean E; Goujani R; Rahimian G; Ahamdi A
    Clin Exp Hepatol; 2019 Sep; 5(3):224-231. PubMed ID: 31598559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.
    Amirkalali B; Poustchi H; Keyvani H; Khansari MR; Ajdarkosh H; Maadi M; Sohrabi MR; Zamani F
    Iran J Public Health; 2014 Sep; 43(9):1275-83. PubMed ID: 26175982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.
    George ES; Roberts SK; Nicoll AJ; Reddy A; Paris T; Itsiopoulos C; Tierney AC
    Intern Med J; 2018 Nov; 48(11):1369-1376. PubMed ID: 29845719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.
    Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B
    Liver Int; 2009 Feb; 29(2):159-63. PubMed ID: 18492015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Amiri Dash Atan N; Koushki M; Motedayen M; Dousti M; Sayehmiri F; Vafaee R; Norouzinia M; Gholami R
    Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S1-S7. PubMed ID: 29511464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.